$329 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 27 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 84.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $180,816,000 | -26.0% | 1,240,932 | -39.8% | 54.93% | +13.7% |
| New | QUIDELORTHO CORP | $48,518,000 | – | 499,263 | +100.0% | 14.74% | – | |
| OPK | Sell | OPKO HEALTH INC | $18,349,000 | -40.6% | 7,252,756 | -19.3% | 5.57% | -8.8% |
| MRNA | New | MODERNA INC | $12,814,000 | – | 89,700 | +100.0% | 3.89% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $11,748,000 | – | 175,000 | +100.0% | 3.57% | – |
| AGEN | Sell | AGENUS INC | $9,033,000 | -57.8% | 4,656,132 | -46.5% | 2.74% | -35.2% |
| Buy | SEMA4 HOLDINGS CORP | $8,298,000 | -31.5% | 6,585,354 | +66.9% | 2.52% | +5.3% | |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $6,390,000 | -77.2% | 603,994 | -64.9% | 1.94% | -64.9% |
| CFRX | Buy | CONTRAFECT CORP | $6,046,000 | -15.2% | 1,969,222 | +0.8% | 1.84% | +30.3% |
| FORA | Buy | FORIAN INC | $5,854,000 | -33.4% | 1,333,477 | +5.7% | 1.78% | +2.4% |
| TQQQ | New | PROSHARES TRultrapro qqq | $3,600,000 | – | 150,000 | +100.0% | 1.09% | – |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $3,553,000 | -68.1% | 803,845 | -34.4% | 1.08% | -51.1% |
| IMMP | Buy | IMMUTEP LTDsponsored ads | $3,161,000 | +18.2% | 1,557,325 | +59.5% | 0.96% | +81.5% |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $2,428,000 | -38.3% | 2,445,791 | -10.5% | 0.74% | -5.1% |
| PFE | New | PFIZER INCcall | $1,513,000 | – | 500,000 | +100.0% | 0.46% | – |
| Sell | DERMTECH INC | $1,366,000 | -85.7% | 246,569 | -62.2% | 0.42% | -78.1% | |
| CDAK | Sell | CODIAK BIOSCIENCES INC | $1,336,000 | -57.8% | 463,998 | -8.0% | 0.41% | -35.1% |
| PNT | New | POINT BIOPHARMA GLOBAL INC | $884,000 | – | 129,810 | +100.0% | 0.27% | – |
| MRTX | New | MIRATI THERAPEUTICS INCcall | $753,000 | – | 60,600 | +100.0% | 0.23% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INCcall | $656,000 | – | 350,000 | +100.0% | 0.20% | – |
| VTNR | Buy | VERTEX ENERGY INC | $598,000 | +9.3% | 56,800 | +3.3% | 0.18% | +68.5% |
| BIIB | BIOGEN INC | $492,000 | -3.1% | 2,412 | 0.0% | 0.15% | +49.0% | |
| AWH | Sell | ASPIRA WOMENS HEALTH INC | $428,000 | -80.6% | 728,100 | -65.6% | 0.13% | -70.1% |
| SLNO | SOLENO THERAPEUTICS INC | $394,000 | -17.1% | 2,132,000 | 0.0% | 0.12% | +27.7% | |
| ACAD | New | ACADIA PHARMACEUTICALS INCcall | $48,000 | – | 300,000 | +100.0% | 0.02% | – |
| VTNR | New | VERTEX ENERGY INCcall | $49,000 | – | 150,300 | +100.0% | 0.02% | – |
| New | VELO3D INC | $42,000 | – | 30,379 | +100.0% | 0.01% | – | |
| PTIX | Exit | PROTAGENIC THERAPEUTICS INC | $0 | – | -20,000 | -100.0% | -0.00% | – |
| ABUS | Exit | ARBUTUS BIOPHARMA CORP | $0 | – | -50,000 | -100.0% | -0.03% | – |
| QDEL | Exit | QUIDEL CORPput | $0 | – | -26,500 | -100.0% | -0.04% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO Lput | $0 | – | -20,000 | -100.0% | -0.04% | – |
| OPK | Exit | OPKO HEALTH INCput | $0 | – | -749,900 | -100.0% | -0.06% | – |
| Exit | DERMTECH INCput | $0 | – | -193,800 | -100.0% | -0.18% | – | |
| ACAD | Exit | ACADIA PHARMACEUTICALS INCput | $0 | – | -459,300 | -100.0% | -0.21% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INCput | $0 | – | -550,000 | -100.0% | -0.25% | – |
| PFE | Exit | PFIZER INCput | $0 | – | -550,000 | -100.0% | -0.25% | – |
| CNC | Exit | CENTENE CORP DELput | $0 | – | -300,000 | -100.0% | -0.29% | – |
| LABU | Exit | DIREXION SHS ETF TRput | $0 | – | -1,000,000 | -100.0% | -0.35% | – |
| IBRX | Exit | IMMUNITYBIO INC | $0 | – | -400,013 | -100.0% | -0.44% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -186,789 | -100.0% | -0.90% | – |
| ATRS | Exit | ANTARES PHARMA INC | $0 | – | -1,720,000 | -100.0% | -1.39% | – |
| ARKK | Exit | ARK ETF TRinnovation etf | $0 | – | -250,000 | -100.0% | -3.28% | – |
| QDEL | Exit | QUIDEL CORP | $0 | – | -708,631 | -100.0% | -15.76% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.